MB Inovatyvūs medicininių veido kaukių priedų sprendimai ir prekyba Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
3,498 |
- |
7 |
7 |
- |
4.87 |
897.74 |
1.66 |
0.20 |
19 |
17,057 |
0 |
17,076 |
2023 |
---|
6,750 |
- |
529 |
503 |
- |
2.60 |
40.41 |
18.73 |
7.45 |
522 |
21,096 |
0 |
21,618 |
2024 |
---|
1,380 |
- |
385 |
366 |
- |
12.98 |
23.74 |
50.29 |
26.52 |
888 |
21,080 |
0 |
21,968 |
Register and
explore Okredo data2024 |
---|
1,380 |
- |
385 |
366 |
- |
12.98 |
23.74 |
50.29 |
26.52 |
888 |
21,080 |
0 |
21,968 |
Register and
explore Okredo data2024
Turnover (€)
1,380 €-80 % *
Sales per employee (€)
-Profit before tax (€)
385 €-27 % *
Net Profit (€)
366 €-27 % *
Profit per employee (€)
-Working capital requirement
12.98 399.23 % *
Debt-to-equity ratio
23.74 -41.25 % *
Total profitability (%)
50.29 %168.50 % *
Net profitability (%)
26.52 %255.97 % *
Equity (€)
888 €70 % *
Amounts Payable And Liabilities (€)
21,080 €0 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
21,968 €2 % *